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Mycothiol (MSH) and ergothioneine (ERG) are thiols able to compensate for each other to protect
mycobacteria against oxidative stress. Gamma-glutamylcysteine (GGC), another thiol and an intermediate
in ERG biosynthesis has detoxiﬁcation abilities. Five enzymes are involved in ERG biosynthesis, namely
EgtA, EgtB, EgtC, EgtD and EgtE. The role of these enzymes in the production of ERG had been unclear. On
the other hand, the enzyme MshA is known to be essential for MSH biosynthesis. In this manuscript, we
describe the raw data of the generation and characterization of Mycobacterium tuberculosis (M.tb) mutants
harbouring a deletion of the gene coding for each of these enzymes, and the raw data of the phenotypic
characterization of the obtained thiol-deﬁcient M.tb mutants. High throughput screening (HTS) of off-
patent drugs and natural compounds revealed few compounds that displayed a higher activity against the
thiol-deﬁcient mutants relative to the wild-type strain. The mode of action of these drugs was further
investigated. Raw data displaying these results are described here.
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Background & Summary
Mycothiol (MSH) and ergothioneine (ERG) are the major thiols of actinomycetes1. In order to better
understand the role of these molecules, it is necessary to elucidate their biosynthesis, enzymes involved
and the signiﬁcance of each enzyme in the production of these thiols. Mycothiol biosynthesis has been
described, requiring MshA, MshB, MshC and MshD, catalysing each a step (Fig. 1). However, only MshA
and MshC are essential for MSH biosynthesis2–4. Mutants deﬁcient in MshA and consequently MSH have
been successfully generated in Mycobacterium tuberculosis (M.tb) (the causative agent of tuberculosis5).
However, viable MshC-deﬁcient M.tb mutants cannot be obtained, indicating, that MshC (but not MSH)
is essential for the in vitro growth of M.tb3,4,6. On the other hand, ERG biosynthesis was speculative until
recently when it was indicated that ﬁve enzymes EgtA, EgtB, EgtC, EgtD, EgtE catalyse each a step in ERG
biosynthesis in M. smegmatis7 (Fig. 1). They are encoded by genes clustered in an operon (Table 1)7.
Therefore, we performed a homology search to identify the corresponding genes in M.tb (Table 1).
This enabled us to generate M.tb mutants deﬁcient in each enzyme, by generating an in frame deletion
of each encoding gene8 (Table 1). In addition, in order to relate the role of ERG to MSH, a MSH-deﬁcient
mutant was generated through an in frame hygromycin marked deletion of mshA8 (Table 1).
Intracellular8 and extracellular9 thiol levels of the generated mutants were measured by liquid
chromatography tandem mass spectrometry (LC-MS).
The enzyme EgtA catalyses the formation of gamma-glutamylcysteine (GGC), an intermediate in ERG
biosynthesis (Fig. 1)7 in mycobacteria and glutathione (GSH) biosynthesis in eukaryotes where it has
anti-oxidative and anti-nitrosative detoxiﬁcation roles10,11. The production of ERG was completely
abolished in the ΔegtD and ΔegtB mutants, the production of GGC was completely abolished in the
ΔegtAmutant which produced a very low level of ERG8, and the production of MSH was abolished in the
ΔmshA mutant as previously shown4,8. Therefore, in order to explore the potential detoxiﬁcation role of
GGC in M.tb, we investigated the susceptibility of the generated GGC/ERG-deﬁcient ΔegtA mutant
relative to the MSH-deﬁcient ΔmshA mutant and the ERG-deﬁcient ΔegtD and ΔegtB mutants in various
in vitro stress conditions8. Thiols biosynthetic enzymes are attractive drug targets. Nevertheless, standard
tuberculosis (TB) regimens consist of more than one drug. However, the ΔmshA mutant is resistant to
few current anti-TB drugs such as ethionamide and isoniazid3,4,12, suggesting that potential inhibitors of
MshA such as UDP-(5F)-GlcNAc13 may not be suitable in combination with ethionamide, neither
isoniazid. Therefore, in order to explore the possibility to repurpose off-patent drugs, and in order to
explore the potential of natural compounds in a combination therapy with potential drugs that target
thiols biosynthesis, we explore the activity of few compounds against the thiol-deﬁcient mutants. An
initial high throughput screening (HTS) of two libraries of compounds (off-patent drugs and natural
compounds) against thiol-deﬁcient M. smegmatis mutants was performed. M. smegmatis is a surrogate/
model for M.tb during investigations14,15, because it is easier to manipulate since it is not pathogenic14,15.
In addition, it facilitates experimental optimizations since it is fast-growing (doubling time of ~3-4 h
relatively to a doubling time of ~24 h for M.tb)14,15, taking into account that the HTS required a series
of optimizations. Few hits were obtained by the HTS9. Four hits were further expounded on M.tb,
namely azaguanine (Aza), sulfaguanidine (Su), bacitracin (Ba) and fusaric acid (Fu). They were tested
against thiol-deﬁcient M.tb mutants by growth proﬁles analysis under the various treatments9.
The growth inhibition of each compound on each strain was calculated from the growth curves raw data.
To further understand the mechanism of action of these compounds in relation to thiols, the ability
of these compounds to modulate the level of thiols (relative to the untreated controls) was investigated
by LC-MS9. Since the general role of thiols is to protect cells against oxidative stress16, the ability of these
compounds to generate oxidative stress (relative to the untreated controls) was also evaluated9. This was
achieved by measuring the ﬂuorescence intensity of the highly ﬂuorescent 2',7'-dichloroﬂuorescein
(DCF)17 that resulted from the cleavage by oxidation of the acetate groups of the non-ﬂuorescent
2′,7′-dichloroﬂuorescein diacetate (DCFDA). Furthermore, para-aminobenzoic acid (pB) is able to
antagonise sulphonamides, because they target the folate pathway where pB is an intermediate18,19.
However, it was still unknown if it was able to antagonise Su and consequently implicating Su mode of
action in the folate pathway. Therefore, the ability of pB to counteract the oxidative stress generated by Su
was investigated and demonstrated9 with the aid of DCFDA. On the other hand, the ΔegtD mutant was
resistant to Aza, a phenotype that was reversed in the complemented strain9, suggesting that EgtD is a
possible target of Aza. In addition, Aza is able to inhibit the synthesis of S-adenosyl methioneine (SAM)20,
which is the co-factor of EgtD (Fig. 1). However, it was impossible to rapidly investigate and clarify the
mechanistic effect of the inhibition of the biosynthesis of SAM by Aza on the activity of EgtD. Since this
happens intracellularly, it may implicate many other pathways. However, as a proof of concept, we
investigated the activity of EgtD in the presence of a compound (chloroquine) that is known to bind to
the SAM binding pocket of SAM-dependent enzymes21. As such, the ability of chloroquine to inhibit the
activity of SAM-dependent enzymes such as EgtD and the human histamine methyltransferase (HNMT)
was demonstrated9. Furthermore, to elucidate the source of extracellular thiols, and justify their
extracellular detoxiﬁcation role such as in the case of the detoxiﬁcation of Ba, the membrane integrity of
the thiol-deﬁcient M.tb mutants was analysed9 by ﬂow cytometry with the aid of propidium iodide (PI)
that penetrates only damaged membrane and Syto 9 that penetrates any membrane22. Since Ba is a high
molecular weight compound (impeding its penetration in mycobacteria)23, to further explain the
susceptibility of the ΔegtEmutant to Ba, the alteration of the cell membrane lipid proﬁle of this strain was
www.nature.com/sdata/
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investigated9. Mycobacteria with a thick lipid layer have a high tendency to aggregate in liquid cultures
because of their hydrophobicity24,25. Therefore, we initially tested the ability of the ΔegtE mutant to form
visual aggregates during the stationary phase of growth9. Osmium tetroxide is a stain used during
microscopy, the higher the lipid content of the stained cells, the darker they appear (under the
microscope)26. Therefore, we also tested the ability of this mutant to react with the osmium tetroxide
stain using scanning electron microscopy (SEM)9. Finally we investigated its ability to form a bioﬁlm9,
since mycobacteria with altered lipid proﬁles hardly form bioﬁlms26,27. Finally, we could relate the mode
of action of these compounds to current anti-TB drug such as rifampicin and isoniazid9 through a
checkerboard28 assay to determine their combined effect on mycobacterial growth. The workﬂow of the
data presented in this study is displayed in Fig. 2. In these studies, we were able to determine the enzymes
that were essential for ERG biosynthesis8. In addition, we were able to evaluate for the ﬁrst time in M.tb
the detoxiﬁcation role of GGC as a potential thiol in relation to ERG and MSH8. Furthermore, we were
able to give a brief evaluation of the physiology of the mutants deﬁcient in each ERG biosynthetic enzyme
and each thiol8,9. Finally, we were able to investigate the potential activity and mode of action of few
compounds against the generated mutants in order to provide a rationale for further investigations into
Figure 1. Simpliﬁed illustration of MSH biosynthesis and ERG biosynthesis. (a) The enzymes involved in
MSH biosynthesis are Ino1, MshA, MshA2, MshB, MshC and MshD. MshA and MshC are essential for MSH
biosynthesis. (b) The enzymes involved in ERG biosynthesis are EgtA, EgtB, EgtC, EgtD and EgtE7. EgtD and
EgtB are essential for ERG biosynthesis. UPD: uridine diphosphate.
www.nature.com/sdata/
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the possibility to repurpose/introduce these drugs in combination with potential inhibitors of thiol
biosynthetic enzymes in a TB regimen. Raw data of these studies are described here and deposited in
appropriate repositories (Data Citation 1–3).
Methods
Generation of theM.tbmutants8 was achieved by a two-step homologous recombination (HR) method as
previously described29–31 with few modiﬁcations (Fig. 3) (Data Citation 1). The following methods are
expanded versions of descriptions in our related work8.
Design of the deletion constructs
Primers8 used to amplify the upstream (US) and downstream (DS) regions of the target genes were
designed with the programs known as DNAman (http://www.lynnon.com/) and GENtle (http://gentle.
magnusmanske.de/). Designed primers ﬁt the following criteria.
The upstream (US) and downstream (DS) regions were more or less 2,500 base pairs (bp) to minimize
illegitimate HR (HR occurring between non-homologous regions).
Restriction sites (RS) were added at the extremities of each primer to enable subsequent cloning to the
vector p2NIL. The chosen RS were found in the p2NIL multiple cloning site (MCS) but not in the US and
DS regions that were ampliﬁed.
The RS of the reverse primer of the US fragment was identical to the RS of the forward primer of the
DS fragment to enable a two-way ligation of the two fragments into p2NIL (Fig. 4a).
The sequence of each primer designed to amplify the US and DS regions of each target gene has been
described8. For the design of the speciﬁc constructs in this study, the restriction sites that met the criteria
described above were for BsrgI (AauI) at the 5’-end of the forward primer (FP) of the US, SpeI at the 5’-
end of the reverse primer (RP) of the US and the FP of the DS, HindIII at the 5’-end of the RP of the DS
(Fig. 4a). These fragments were ampliﬁed by a High-Fidelity DNA Polymerase that enabled an accurate
ampliﬁcation of the targeted regions while taking into account the GC rich content of the M.tb genome.
Final constructs were screened by restriction enzyme digestions (RED) (Supplementary Fig. S1-S9)
and by sequencing (Designed sequencing primers are P2nilF: GTTTACGAGAGAGATGATAG, P2nilR:
ACGGTGCCTGACTGCGTTAG) (Data Citation 1). The plasmids with a satisfactory integrity that
prevented E.coli from growing on sucrose containing plates were used as the allelic substrate to achieve
deletion of the gene egtA (p2NILA/G17), egtB (p2NIlB/G17), egtC (p2NIlC/G17), egtD (p2NIlD/G17),
egtE (p2NIlE/G17), mshA (p2NIlmshA/G17) (Data Citation 1). Deletion of egtA, egtB, egtC, egtD, egtE
and mshA proceeded as described in Fig. 3. A colony or more of each mutant conﬁrmed by PCR
(Supplementary Fig. S10-S16) was further validated by Southern blotting8. Genomic extraction and
southern transfer of digested genomic DNA was performed as previously described32, however, the
detection steps were performed with the aid of the DIG High Prime DNA labelling and detection kit II
and the DIG wash and block Buffer set (Roche Diagnostic GmbH Mannheim, Germany) according to
manufacturer’s instructions. The methods used to design the complementation constructs have been
described8 (Designed sequencing primers are pMV-R TGGCAGTCGATCGTACGCT, pMV-F:
CCGGGCTGCAGGAATTCGATAT) (Data Citation 1).
Enzyme EgtA EgtB EgtC EgtD EgtE MshA
Gamma-glutamylcysteine
synthase
sulfoxide
synthase
glutamine amidohydrolase S-adenosylmethionine-
dependent methyltransefrase
C-S lyase Mycothiol glycosyl transferase
Gene egtA egtB egtC egtD egtE mshA
ORFa in M.
smegmatis
MSMEG_6250 MSMEG_6249 MSMEG_6248 MSMEG_6247 MSMEG_6246 MSMEG_0924
ORF in M.tb
(H37Rv)
Rv3704c Rv3703c Rv3702c Rv3701c Rv3700c Rv0486
ORF in M.tb
(CDC1551)
MT3807 MT3806 MT3805 MT3804 MT3803 MT0504
M. smegmatis
mutants
_ _ _ Unmarked HRb mutant, ΔegtD12 _ Kanamycin marked, transposon
mutant ΔmshA2
M.tb mutants
(H37Rv)
_ Unmarked HR
mutant,
ΔegtB8
_ _ Unmarked HR mutant, ΔegtE8
M.tb mutants
(CDC1551)
Unmarked HR
mutant ΔegtA8
Unmarked HR
mutant ΔegtB8
Unmarked HR mutant ΔegtC8 Unmarked HR mutant ΔegtD8 Unmarked HR mutant ΔegtE8 Hygromycin marked HR mutant, ΔmshA8
Table 1. Gene annotations and mutants used in this study. aOpen reading frame. bHomologous
recombination.
www.nature.com/sdata/
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Sample preparation for the metabolomics analysis of the mutants
Sample preparation for the quantiﬁcation of thiols by liquid chromatography tandem mass spectrometry
(LC-MS) has been described in our previous work8,9 (Fig. 4b) and the raw mass spectra ﬁles are in the
Metabolights repository (Data Citation 1). Derived and calculated data are described in the current work
(Data Citation 1). Results derived from samples were prepared using two methods.
Sample preparation method-1
Brieﬂy, exponential and stationary cultures were re-suspended in a pre-made extraction buffer
((40% acetonitrile (ACN) + 0.25 M perchloric acid (PA) + 2 mM ethylenediaminetetraacetic acid
(EDTA)). After physical cell lysis by bead beating, the pH of the cell lysate was equilibrated to ~8 with
ammonium bicarbonate (ABC). The suspension was further derivatized with a ﬁnal concentration of 2
mM monobromobimane (mBBr, 60 °C for ~15 min). For the quantiﬁcation of MSH using this method,
sample were dithiothreitol (DTT)-treated prior derivatization (0.02M DTT, 10 min at room
temperature). For the quantiﬁcation of ERG, the pH-equilibrated cell lysate was lyophilized and re-
suspended in a resuspension buffer (2.48 mg/ml diethylenetriaminepentaacetic acid (DTPA) in 0.1%
triﬂuoroacetic acid (TFA)). The suspension was added to a derivatization buffer (2.48 mg/ml DTPA + 48
mg/ml HEPES + 0.7 mM mBBr, pH 8.2) at a ratio of ~1:2 and incubated further for derivatization. For
every extraction, the extracellular fractions were lyophilized and treated exactly as the intracellular
fractions (Data Citation 1).
Sample preparation method-2
The ﬁrst method consists of many steps that may have been the cause for the large variation between
biological replicates, even when sample were DTT-treated as was the case of MSH quantiﬁcation (Data
Citation 1). However, the trend of difference between strains was conserved in most cases8. In addition,
GGC, which was the most labile thiol, was hardly detected with method-1 (~1.4 Þg/1010 CFU in the wild-
type versus ~14.6 Þg/1010 CFU in the ΔegtB mutant where it accumulates). This suggests that, the higher
the number of steps during extraction, the more likely thiols are to oxidize and/or degrade. Therefore, we
used a second relatively straightforward method to improve the quantiﬁcation, focusing on the mutants
that displayed the phenotype we were investigating8. In addition, we used the second method to quantify
the level of thiols after various drugs treatment9 (Data Citation 1). The second method is described as
follows. Brieﬂy, as previously described with few modiﬁcations4, cell pellets and lyophilized extracellular
fractions from stationary phase cultures were re-suspended in the lysis/derivatization buffer (50% warm
ACN + 20mM Hepes pH~ 8 + 2mM mBBr) and sonicated in a water bath sonicator at 60 °C for ~30
min. This was further acidiﬁed with ~1 mM acetic acid and stored at −20 or −80 °C for the LC-MS
analyses.
Figure 2. Workﬂow of experiments and data presented in this manuscript. ROS: reactive oxygen species,
RNS: reactive nitrogen species.
www.nature.com/sdata/
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Figure 3. Gene deletion process adapted from previously described methods. (a) The upstream and the
downstream regions of the targeted gene were ampliﬁed and subsequently cloned separately into any
commercially available sub-cloning vector. Next, these fragments were excised by restriction enzyme digestions
(RED) from these vectors and simultaneously ligated into a p2NIL vector that was previously linearized by
RED. Then the PacI fragment of Pgoal17 (containing the sacB gene coding for levan sucrose for sucrose
sensitivity and Lac-z gene coding for the β-galactosidase which breaks down X-gal to yield a blue product) was
ligated to the p2NIL vector linearized by PacI. After conﬁrmation of the integrity of the resulting construct by
RED and by sequencing, it was used to achieve gene deletion as indicated. (b) After transformation of
mycobacteria with the designed construct, a homologous recombination (HR) event occurs between the US
(HR-1) or DS (HR-2) to give rise to single cross over (SCO) colonies that have incorporated the entire plasmid
into their genome. The second HR event occurs after sub-culturing these colonies without antibiotics, giving
rise to either a wild-type strain, or a strain with the deleted gene. Deletion was thereby conﬁrmed by PCR and
southern blotting analyses. Kan: kanamycin, X-gal: 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside, aph:
kanamycin resistance gene, bla: ampicillin resistance gene; US: upstream, DS: downstream, WT: wild-type,
SCO: single cross over, DCO: double cross over.
www.nature.com/sdata/
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Figure 4. Experimental Designs. (a) Primers design for the deletion construct. The forward primer (FP) of
the DS region carries RS-A (restriction site-A) identical to the RS of the reverse primer (RP) of the US region
found in the p2NIL vector. RS-B and RS-C are found on either sides of RS-A. (b) Design of the metabolites
extraction method. The supernatant of cultures after centrifugation is used for the quantitation of extracellular
metabolites. The extract from the cells pellet is used for the quantitation of intracellular metabolites.
Derivatization was performed either during or post extraction depending on the method.
www.nature.com/sdata/
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Liquid chromatography tandem mass spectrometry for metabolomics analysis
Quantiﬁcation by UPLC-ESI-MS/MS of MSH was performed with a Waters Acquity UPLC system
coupled to a Waters Xevo TQ MS system (Waters Corporation, Milford, MA, USA). Compounds were
separated on a Waters Acquity HSS T3 column (2.1 x 100mm; 1.7 μm particle diameter) at 40 °C using a
gradient of 0.1% formic acid/water (solvent A) to 0.1% formic acid/acetonitrile (solvent B) at a ﬂow rate
of 0.35 ml/min. The acetonitrile concentration was increased linearly to 50% over 9 min, and thereafter to
100% after 10 min. The column was re-equilibrated for 3.5 min (the total run time was 14 min). The
source capillary was held at 3 kV. The source and de-solvation temperatures were 140 °C and 400 °C,
respectively. The de-solvation and cone gas ﬂows were 600 and 50 liters/h, respectively. Quantiﬁcation by
UPLC-ESI-MS/MS of other metabolites (ERG, GGC and hercynine) was performed similarly with the
same system. Compounds separation was performed using the same column speciﬁcation at 40 °C using a
gradient of 10 mM ammonium acetate/water (solvent A) to 49:49:2% acetonitrile:methanol:isopropanol
(solvent B) at a ﬂow rate of 0.34 ml/min. Solvent B was increased to 1% after 1 minute, followed by linear
increases to 6% at 10.5 min, 15% at 12 min, 90% at 13 min where it was held until 13.5 min. The column
was re-equilibrated for 3.4 min (the total run time was 17 min).
Analysis of metabolomics raw data
For absolute quantiﬁcations such as that of ERG and GGC, the concentration derived from the standard
curve was given in þg/μl. The total amount per vial was calculated by multiplying the given concentration
by the total resuspension volume. This was further divided by the total volume of culture from which the
sample was extracted, to have the ﬁnal concentration per ml of culture, which was subsequently divided
by the predetermined CFU per ml of culture for each strain (Data Citation 1).
For the relative quantiﬁcations such as that of MSH the given peak area was multiplied by half the
total resuspension volume (assuming the peak area corresponds to 2 μl, since the injection volume was 2
μl) (Data Citation 1). However, for the quantiﬁcation of hercynine, we considered an injection volume of
1 μl (Data Citation 1). The total peak area was divided by the culture volume and subsequently by the
CFU count as described above (Data Citation 1). Alternatively, ERG standard curve was used to deduce
the absolute concentration of MSH in the data deriving from the second method8,9 (Data Citation 1).
Flow cytometry analysis of mycobacteria membrane integrity
The following method is an expanded version of description in our related work9. One millilitre of
exponential M.tb cultures was pelleted, washed twice and re-suspended in 150 mM NaCl. One hundred
microliters of the cell suspensions was added to BD Falcon tubes containing 977.4 μl of the running buffer
(148 mM NaCl, 22 μM propidium iodide (PI) and 5 μM Syto9). Stained M.tb cells were analysed using a
BD FACSJazz cell sorter (Becton Dickinson Biosciences, Belgium). Acquired data (Data Citation 3) were
analysed using the program known as FlowJo (10.1r7). The instrument settings were adjusted according
to the unstained sample (Fig. 5a) (Data Citation 3) that enabled to set the threshold and the single-stained
samples (either with PI (Fig. 5b) or with Syto9 (Fig. 5c)) that enabled to set ﬂuorescence compensations
in order to correct for overlaps. Samples stained with both dyes were subsequently acquired after
adjustments of the instrument settings (Fig. 5d). As controls, sodium dodecyl sulphate (SDS)-treated
samples (~1h in 0.05% SDS) were included (Fig. 5e), based on previous studies indicating that SDS is
able to damage bacterial membrane33. Heat-treated samples (80 °C for ~1h) (Fig. 5f) were added
as additional controls based on previous indications that heat treatment under these conditions
was detrimental to mycobacteria34,35. The wild-type and the mutants were subsequently analysed9 (Data
Citation 1) (Data Citation 3).
Growth curves generation
The following methods are expanded versions of descriptions in our related work8,9. Frozen stocks were
used to start approximately 5 ml of culture in 25 cm2 vented tissue culture ﬂasks (starter culture). After
approximately a week or more of incubation at 37 ºC, the OD600 of the cultures was measured. This was
used to calculate how much was needed to inoculate 40 ml of media (in a 75 cm2 vented tissue culture
ﬂask) to a starting OD600 of 0.05, supplemented with OADC (Oleic acid, albumin, dextrose and catalase)
or ADS (albumin, dextrose and sodium chloride) with or without ERG8. The OD600 of each culture was
recorded every second day (Data Citation 1). Alternatively, the starter culture was used to inoculate a
smaller volume (10 ml) of culture media (in 25 cm2 vented tissue culture ﬂasks) with or without the
potential compounds identiﬁed through the high throughput screening9. The OD600 was recorded
likewise every second day (Data Citation 1). M. tuberculosis strains were cultured without shaking at
37 °C; the ﬂasks were placed and packed ﬂat in sealable plastic containers that were double-sealed in
plastic bags. The dose response curves of the M. smegmatis mutants were generated by a different
method, with the aid of a plate reader in ﬂat bottom dark 96-well plates as described9 (Data Citation 1).
Susceptibility tests
Methods used to investigate mutants susceptibility to oxidative and nitrosative stress have been
described8 (Data Citation 1). The method used to investigate their survival within THP1 macrophages
has been described as well8 (Data Citation 1).
www.nature.com/sdata/
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The investigation of the susceptibility of the mutants to antibiotics by growth curve analyses9 is
described in the previous section. The growth inhibition was calculated by subtracting the OD600 of the
treated culture from the OD600 of the untreated culture. Further dividing that by the OD600 of the
untreated culture and ﬁnally multiplying by 100 ( Data Citation 1).
Measurement of the levels of oxidative stress
This was achieved with the aid of the compound known as 2′,7′-dichloroﬂuorescein diacetate (DCFDA)
as previously described9,17. An expanded version of our previous description9 is as follows. Brieﬂy,
DCFDA purchased from Sigma Aldrich (D6665-5G) was dissolved in DMSO to make a ﬁnal
concentration of 10 mM that was stored at -20 °C as the main stock. This was subsequently diluted to 1
mM stocks that were used to perform the analyses. Initial measurements consisted to stain 1 ml of
mycobacteria cultures (grown to the stationary phase with or without treatment) with a ﬁnal
concentration of 10 μM of DCFDA. A volume of 100 μl was aliquoted in replicates in a dark 96-well plate
(with an optical ﬂat bottom). After incubation for 70 min at 37 ºC, measurements were performed at an
excitation wavelength of 488 nm and emission wavelength of 520 nm with the aid of a plate reader
(Data Citation 1). The relative ﬂuorescence unit obtained was normalised with the CFU counts (Data
Citation 1). Alternatively, in order to investigate the ability of pB to counteract the oxidative stress
generated by Su, mycobacteria grown to an OD600 ~ 0.2 were treated with either Su, or pB or a
combination of Su and pB. Since pB was dissolved in sterile double distilled H2O (2.5 mg/ml), H20 was
used to compensate for the volume of pB in the culture treated only with Su. On the other hand, since Su
was dissolved 75% HCl (25 mg/ml), 75% HCl was used to compensate for the volume of Su in the culture
treated only with pB. Treated cultures were immediately stained and the ﬂuorescence intensity of DCF
was measured every 10 min for 90 min at 37 °C (Data Citation 1).
Investigation of the activity of EgtD and HNMT
Cloning, expression and puriﬁcation of EgtD and HNMT have been described9. A more detailed
description of the enzymatic assays from our previous work9 is as follows. The assays were performed
with the aid of the SAMﬂuoro: SAM Methyltransferase Assay kit (G-Biosciences 9800 Page Avenue St.
Louis, MO 63132-1429 USA) based on the following principle. During SAM mediated methylation by a
methyltransferase, S-adenosylhomocysteine (AdoHcy) is released and converted to resofurin through a
series of enzymatic reactions. The production of resofurin, which is proportional to the enzymatic
activity, is therefore continuously quantiﬁed over time with a plate reader (the Inﬁnite 200 PRO TECAN
multimode microplate reader in this case) at an excitation wavelength of 530–540 nm and emission
wavelength of 585–595 nm (Data Citation 1). Optimized speciﬁcations of the enzymatic reactions
investigated in this study have been described9 (167 μM S-adenosylmethionine (SAM), 87 μM substrate
and 42 nM enzyme). For cost effectiveness, initial investigations were performed to determine if the
assays would function optimally at a scaled down reaction volume. This was achieved using 10 times less
the manufacturer’s recommended volume (ﬁnal reactions volume was 11.5 μl instead of 115μl performed
in a dark ﬂat bottom 384-well plate instead of a 96-well plate). The standard curves indicated a good
correlation (See Supplementary Fig. S17), which prompted further investigations using smaller reaction
volumes as described9.
Drug combination studies (Checkerboard assays)
The results describing the effect of drugs in combination9 were obtained from drug combination studies
performed as previously described28 but with few modiﬁcations as follows. The ﬁrst compound was
serially diluted from the 12th to the 1st row of a 96 well plate (ﬁrst plate). Then the second compound was
serially diluted from the H-column to the A-column of another 96 well plate in 7H9 supplemented with
ADS (Second plate). Further, 50 μl of the diluted compound from every well of the ﬁrst plate was
transferred in the same order to every row except the 1st row (where 50 μl of 7H9 was added instead, this
served as the MIC control of the second compound) of a U-bottom 96 well plate (third plate). In addition,
50 μl of the serially diluted compound of the second plate was transferred to the third plate excluding the
A-column (where 50 μl of 7H9 was added instead, this served as the MIC control of the ﬁrst compound).
Finally, 50 μl of early logarithmic phase mycobacterial cultures re-suspended to an OD~0.01 was added
in every well of the third plate to make up a ﬁnal volume of 150 μl. This was incubated for ≥7 days.
Results were analysed by looking at the mycobacterial pellet formed at the bottom of the U-bottom plate
or with the aid of the growth indicator resazurin36. For bactericidal compounds, the MIC (minimum
inhibitory concentration) was determined as the concentration of the well with complete growth
inhibition that was next to the well where growth was obvious. For bacteriostatic compounds, the MIC
was determined as the concentration of the well with the smallest bacterial pellet size that was next to a
bigger pellet size. The MIC of each compound (not in combination) previously determined by the broth
micro dilution method37 was conﬁrmed during the checkerboard assay from column-A (ﬁrst compound)
and the ﬁrst row (second compound). Finally, the MIC in combination was determined from other wells.
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Figure 5. Flow cytometry analysis of Mycobacterium tuberculosis. (a) Syto9 versus PI plot of the unstained
sample, indicating a low signal therefore minimal auto ﬂuorescence or background ﬂuorescence. (b) Same
sample stained only with PI. It can only penetrate cells with a damaged membrane either dead or not, which
may explain the low signal since samples derived from actively growing cultures. (c) Sample stained with only
Syto9. It penetrates every cell irrespective of their viability, which may explain the high signal. (d) Manual
gating of population sub-sets using FlowJo of actively growing mycobacterial cultures stained with PI and
Syto9. The population with a high Syto9 and PI signals was deﬁned as the population of live cells with an intact
membrane (LCIM). The population with a high PI signal and a relatively low Syto9 signal was deﬁned as the
population of dead cells (DC), while the population with a relatively low Syto9 and PI was considered as the
population of live cells with a damaged membrane (LCDM). Every sample was analysed following that pattern.
(e) Samples treated with 0.05% SDS for ~1 h displayed a slight increase of LCDM, indicating that a higher
concentration of SDS or a longer exposure may damage a higher proportion of cell membrane. (f) When heat-
treated, the DC population increased signiﬁcantly.
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Aggregation test during the stationary phase
The ΔegtE mutant and the wild-type CDC1551 strains were cultured to the stationary phase (for 4-8
weeks). Culture were transferred to 50 or 15 ml tubes and allowed to stand for at least ﬁve minutes in
order to enable decantation of aggregates9 (Data Citation 1).
Investigation of bioﬁlm formation by Mycobacterium tuberculosis
The investigation of the ability of M.tb to form a bioﬁlm9 was performed as previously described with
slight modiﬁcations26. As we previously described9, it was perform as follows. Late log phase cultures
were washed twice with an equal volume of Sauton’s medium. These cells were used to inoculate 50 ml of
Sauton’s media to an OD600 of 0.01 in 250 ml sterile polypropylene bottles with tight caps (with no ﬁlters
in order to prevent gas escape). Then it was incubated at 37 °C in a CO2 incubator for 3 to 6 weeks (Data
Citation 1).
Scanning electron microscopy
The investigation of the depletion of the lipid constituents of the membrane of the ΔegtE mutant by
scanning electron microscopy (SEM)9 was performed as follows. Late log phase liquid cultures were
washed twice in an equal volume of Sauton’s medium and plated on 7H11 plates. The lawn of cells
formed on the plate at ~3 weeks of incubation at 37 °C was scraped off, re-suspended in 3.7%
formaldehyde and incubated at 4 °C overnight. The samples were cryoﬁxed, immersed in a dry,
pre-cooled (−85 °C) cocktail of 2% osmium tetroxide (OsO4) (dissolved in anhydrous acetone) kept in a
Leica AFS Automatic Freeze-Substitution unit and subsequently analysed by SEM38,39.
Data Records
The raw Flow Cytometry Standard ﬁles (FCS)9 are deposited in the FlowRepository (Data Citation 3). The
metabolomics raw spectra ﬁles are deposited in the Metabolights repository (Data Citation 2). The
following ﬁles and raw data are deposited in the ﬁgshare repository (Data Citation 1).
Raw and calculated data describing the metabolomics results
The empty cloning vectors, deletion and complementation constructs8 designed with the program
GENtle.
The sequencing results of the designed constructs8 from different set of primers (taking into account
that the ﬁrst 50–100 nucleotides from the sequencing results are usually spurious).
Raw data of every growth curve presented in these studies8,9 (standard conditions (OADC or ADS
supplement) and under treatments).
CFU counts raw data and calculated survival percentage of the various susceptibility tests performed
in these studies8,9.
Raw data of the activity assays of EgtD and HNMT9
Aggregation, bioﬁlm, and SEM pictures from various biological replicates of tested M.tb strains9.
Technical Validation
Constructs generated in this study are sequenced (Data Citation 1). They were also screened by RED (see
Supplementary Fig. S1-S9).
Mutants were screened by PCR (see Supplementary Fig. S10-S16) and conﬁrmed by southern
blotting8, sequence of primers and probes used for screenings have been described8.
Metabolomics analyses were performed from samples deriving from two different cultures of each
strain (cultures started and cells harvested on different days) (Data Citation 1). Results were further
validated in speciﬁc strains using another extraction-derivatization method from another set of two
different cultures8 (Data Citation 1). Intracellular and extracellular fractions were obtained from the same
biological samples and were derivatized in the same buffer, to allow a rational comparison of the data
obtained from both fractions. In order to ensure a rational comparison of thiols levels between different
M.tb strains, their samples were extracted the same day with the same buffer, and analysed during the
same LC-MS run, to rule out any difference that may have arisen because of the difference in the LC-MS
or sample preparation conditions8,9. To minimize spurious interpretations of the levels of thiols under
treatment9 (that may have arisen from dead mycobacteria), treatment was introduced at the start of the
culture (OD600 ~0.05) and the levels of thiols were measured after ~ two weeks of mycobacterial growth
under the selective pressures. This was in order to determine the regulation of the thiols production when
the mycobacteria are cultured in the presence of the compounds relative to the untreated controls (Data
Citation 1). That’s why it was not investigated at the compounds MICs but rather at their average MIC,
since this was the average of the minimum concentration that completely inhibited growth and the
maximum concentration that did not inhibit growth9 determined by the broth micro dilution method37.
For more accuracy, the levels of thiols in these studies8,9 were normalized with the CFU counts in order to
directly relate their levels to the viable mycobacterial cells (Data Citation 1).
Likewise, the ﬂuorescence intensity of DCF measured in treated cultures was normalised with the CFU
counts of each culture9 (Data Citation 1). In addition, the level of ROS and thiols were measured from the
same biological samples in order to be able to directly relate the level of thiols to the level of ROS
measured in each treated sample9 (Data Citation 1). However, during the investigation of the
counteracting oxidative stress effect of pB on Su9, it was not necessary to normalize the ﬂuorescence
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intensity of DCF with the CFU counts. Since the different conditions were investigated in equal volumes
of the same sample (derived from the same culture, M.tb wild-type at OD~0.2) and measurements were
performed immediately after adding the DCFDA. Thus, the counteracting effect of Su and pB was
monitored over time (Data Citation 1). Nevertheless, we ensured that a uniform percentage of HCl was
included in every tested condition (since Su was dissolved in HCl) in order to rule out any observation
that may have been associated with HCl. In addition, it was found that HCl quenches the ﬂuorescence of
DCF, which further justiﬁed the addition of the same percentage of HCl in the controls.
Growth curve analyses and susceptibility tests were performed two to four times to ensure
reproducibility of results8,9 (Data Citation 1).
To ensure the appropriate population gating9, heat-treated, SDS-treated, unstained untreated and
ﬁnally single-stained (with either PI or Syto9) samples were included during ﬂow cytometry analyses
(Data Citation 3).
To ensure that the absence of aggregation of the ΔegtE CDC1551 mutant9 was not due to a high
concentration of Tween 80 in the media, every tested strain was grown in the same media. The inability of
the ΔegtE mutant to aggregate was investigated more than once (Data Citation 1). Likewise, the inability
of the ΔegtE mutant to form a bioﬁlm was investigated more than once, from different bacterial stocks
cultured under different conditions (Data Citation 1).
To ensure that the dark colour intensity of the mycobacterial cells9 visualised by SEM was not different
due to the instrument settings during visualization, they were visualised under the same speciﬁcations
(Contrast: 53.3%, Brightness: 49.9%,) (Data Citation 1).
Untreated controls were added during all susceptibility tests that involved prolonged exposures (more
than 48 h for M.tb or more than more than 3 h for M. smegmatis) to make sure that the observed
differences were not due to growth differences (Data Citation 1).
Finally, the susceptibility of the M.tb or M. smegmatis strains to various compounds and the level of
ROS were determined in cultures supplemented with either ADS (for M.tb strains) or GS (0.85% NaCl,
0.2% glucose) (forM. smegmatis strains)9. It was in order to avoid catalase (that is able to react with ROS,
acting as an anti-oxidant40) in the OADC supplement that could compromise the integrity of the results
of the speciﬁc experiments that relied on the ability of the mycobacteria to counteract ROS and the ability
of the tested compounds to generate ROS.
Usage Notes
Researchers interested in reproducing the results generated in these manuscripts. Researchers interested
in reproducing/performing similar experiments in other contexts. Raw data ﬁles are either in excel or
Graph Pad Prism ﬁles. Sequencing results can be analysed with any gene manipulation software and
constructs maps can be open with the program GENtle or any other gene manipulation software.
The library of compounds used for the high throughput screening are the PRESTWICK chemical
(1,280 compounds) and the PRESTWICK phytochemical (320 compounds) libraries. The chemical
library consists of chemical and pharmacological diverse off-patent drugs with known bioavailability and
biosafety data in humans. The phytochemical library consists of natural compounds that mostly derived
from plants.
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